What is a natural mimicker of Glucagon-like peptide-1 (GLP-1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Berberine is a natural mimicker of Glucagon-like peptide-1 (GLP-1), and it can be taken at doses of 500mg 2-3 times daily with meals. When considering natural alternatives to pharmaceutical GLP-1 receptor agonists, it's essential to prioritize options that have been studied for their potential to stimulate GLP-1 production or activity.

  • Berberine, found in plants like barberry and goldenseal, is one of the most studied natural GLP-1 mimickers 1.
  • Other options include bitter melon extract, cinnamon, and fenugreek seeds, which may help stimulate GLP-1 production or activity, although the evidence for these options is not as strong as for berberine.
  • High-fiber foods like oats, legumes, and vegetables naturally stimulate GLP-1 release, as do fermented foods containing probiotics, which can promote improved gut microbiome health 1.
  • Protein-rich meals, particularly those containing specific amino acids like glutamine, can also enhance GLP-1 secretion, making them a potential natural approach to supporting GLP-1 activity. It's crucial to note that while these natural alternatives may help with blood sugar management and appetite control, they are generally less potent than pharmaceutical GLP-1 receptor agonists, such as semaglutide and liraglutide, which have been shown to reduce weight and improve weight-related comorbidities significantly 1.
  • As a result, natural GLP-1 mimickers should be used as complementary approaches rather than replacements for prescribed medications, and their use should be discussed with a healthcare provider to determine the best course of treatment.

From the FDA Drug Label

Liraglutide is an acylated human Glucagon-Like Peptide-1 (GLP-1) receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1(7-37). The FDA drug label does not answer the question.

From the Research

Natural Mimickers of GLP-1

There are no direct references to natural mimickers of Glucagon-like peptide-1 (GLP-1) in the provided studies. However, some studies suggest that certain dietary strategies can sustain the secretion of GLP-1 for improved glucose homeostasis 2.

Dietary Strategies to Sustain GLP-1 Secretion

  • A slow digestion-oriented dietary approach can efficiently reduce the digestion rate of food nutrients and potentiate their distal deposition, leading to a sustained secretion of GLP-1 2.
  • Incorporation of viscous dietary fibers and enzyme inhibitors of phytochemicals in a designed whole food matrix can help reduce the digestion rate of food nutrients and sustain GLP-1 secretion 2.

GLP-1 Receptor Agonists

  • Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been approved as a second-line treatment option for better glycemic control in type 2 diabetes and has shown cardiovascular benefits 3.
  • Other GLP-1 receptor agonists, such as liraglutide and exenatide, have also shown reductions in fasting and postprandial glucose concentrations, and hemoglobin A1c (HbA1c) levels 4.

Related Questions

What are the considerations for adding Ozempic (semaglutide) to the treatment regimen of diabetic patients on insulin and metformin (metformin) with a history of multinodular goiter and known cholelithiasis (gallstones)?
What is the approach for adjusting GLP1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), for diabetes management?
What are the next best steps for managing diabetes in an 88-year-old woman with dementia, mild Chronic Kidney Disease (CKD), and poorly controlled Diabetes Mellitus (DM) on Metformin and Sitagliptin?
Are semaglutide (GLP-1 receptor agonist) tablets available for type 2 diabetes treatment?
What is the most appropriate add-on treatment for a 63-year-old woman with Chronic Kidney Disease (CKD), Heart Failure with Reduced Ejection Fraction (HFrEF), Hypertension, Hypothyroidism, and Type 2 Diabetes (T2D) with worsening Glycemic Control (HbA1c increase) and Impaired Renal Function (eGFR 26 mL/min/1.73 m2), currently on Aspirin, Dapagliflozin, Levothyroxine, Metoprolol Succinate, Rosuvastatin, Sacubitril/Valsartan, and Torsemide?
What is the testosterone level cutoff for initiating doxazosin (alpha-1 adrenergic receptor blocker) therapy in Benign Prostatic Hyperplasia (BPH)?
What supplements are proven to mimic Glucagon-like peptide-1 (GLP-1)?
What is a GLP-1 (Glucagon-like peptide-1) mimicker?
Is a patient with adrenal insufficiency on chronic prednisone (corticosteroid) therapy, presenting with low cortisol levels and labile blood pressure, likely to benefit from transitioning to hydrocortisone (corticosteroid)?
Can osteoma cause headaches?
Does garlic lower Low-Density Lipoprotein (LDL) cholesterol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.